Insight Operating Cycle from 2010 to 2026

IMDX Stock   6.64  0.02  0.30%   
Insight Molecular Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle will likely drop to 283.27 in 2026. During the period from 2010 to 2026, Insight Molecular Operating Cycle regression line of annual values had r-squared of  0.40 and arithmetic mean of  180.16. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
399.74
Current Value
283.27
Quarterly Volatility
205.11380748
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Insight Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insight Molecular's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Selling General Administrative of 11.5 M or Other Operating Expenses of 76 M, as well as many indicators such as Price To Sales Ratio of 18.07, Dividend Yield of 0.0015 or Days Sales Outstanding of 239. Insight financial statements analysis is a perfect complement when working with Insight Molecular Valuation or Volatility modules.
  
Build AI portfolio with Insight Stock
Check out the analysis of Insight Molecular Correlation against competitors.

Latest Insight Molecular's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Insight Molecular Diagnostics over the last few years. It is Insight Molecular's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insight Molecular's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Insight Operating Cycle Regression Statistics

Arithmetic Mean180.16
Geometric Mean112.52
Coefficient Of Variation113.85
Mean Deviation161.67
Median60.93
Standard Deviation205.11
Sample Variance42,072
Range706
R-Value0.63
Mean Square Error26,806
R-Squared0.40
Significance0.01
Slope25.78
Total Sum of Squares673,147

Insight Operating Cycle History

2026 283.27
2025 399.74
2024 444.15
2023 117.54
2022 766.58
2021 381.25

About Insight Molecular Financial Statements

Insight Molecular investors use historical fundamental indicators, such as Insight Molecular's Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Insight Molecular. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 399.74  283.27 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Insight Stock Analysis

When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.